Report Description

Mexico Diagnostic Labs Market is anticipated to witness an impressive growth during the forecast period, 2024-2028.This can be ascribed to the rising prevalence of various chronic diseases among the populations across the country.

Growing prevalence of chronic disease such as cardiovascular disease, cancer has led to the increase in demand for diagnostic Labs for diagnosis purposes and monitoring treatments at different stages of the disease. According to Global Cancer Observatory, there are around 195,499 new cases of cancer reported in Mexico in 2020. Out of these cases 89,536 new cancer cases were reported in males and 105,963 are new cancer cases were reported among females. Breast cancer, cervix uteri cancer, thyroid cancer, colorectum cancer, corpus uteri cancer was the most prevalent five types of cancer among women in the country. In males, the most prevalent five types of cancers reported in 2020 were prostate cancer, colorectum cancer, stomach cancer, lung cancer, and non-hodgkin lymphoma. These statistics illustrate the requirement of regular diagnosis and mandatory check-ups, thereby boosting the growth of Mexico Diagnostic Labs market.

Rising Prevalence of Cardiovascular Diseases

According to the Global Burden of Disease statistics, in 2020-2021, Mexico reported ischemic heart diseases as the leading cause for mortality among the population after the COVID-19 mortality cases. In 2021, 164,461 deaths occurred in the country due to ischemic heart disease conditions, followed by prevalence of diabetes mellitus causing 143,020 deaths. Diseases such as Cerebrovascular disease, Hypertensive diseases, Malignant neoplasms, Digestive diseases and Respiratory infections are highly prevalent in Mexico and thereby are creating a higher demand for the diagnostic labs required for diagnosis and regular monitoring of the disease and symptoms, thus providing the Mexico Diagnostic Labs Market a lucrative growth.

Increased Testing for Infectious Diseases

In Mexico Hepatitis A Virus (HAV) infection is among the leading viral hepatitis among children of age 1-9 years, as the vaccine is yet not included in the national immunization program (NIP) in Mexico. To confirm the hepatitis A Virus, serological testing is performed, which further detects the presence of Immunoglobulin M (IgM) anti-HAV in the in the convalescent phase of the infection. Under diagnosis the IgM antibodies indicate recent infection and IgG antibodies indicate past infection and usually persists throughout an individual’s lifespan after infection or vaccination. The increased testing for Hepatitis A Virus (HAV) infection is giving a boost to the Mexico diagnostic Labs Market growth. Rising incidence of infectious diseases such as typhoid, malaria, herpes simplex, HIV/AIDS and skin diseases is expected to raise the demand for distinct microbiology and cytology test thereby creating a demand for Diagnostic Labs Market growth in the country.

Rising Number of Obesity Cases

Mexico is an emerging country with young demographics, with a consumption of unhealthy food and living a sedentary lifestyle, the country has reportedly observed a larger population with increasing weight and even in overweight conditions. Approximately 75% of Mexico’s adult population is either obese or overweight, which makes the country one of the world’s leading countries in both adult and childhood obesity. With growing population, the unhealthy lifestyle and Obesity-prevalence rate is also rising giving rise to various health conditions such as heart disease, stroke, type 2 diabetes and certain types of cancer. The sedentary lifestyle giving rise to less physical movement due to the office and the new work from home lifestyle along with no physical exercise is creating severe health worsening conditions such as arthritis, hypertension, heart disease, stroke, cancer, and diabetes thereby creating an essential requirement for the diagnostic and testing labs for regular check-ups and monitoring thereby driving the Mexico Diagnostic Labs market growth.

Well Established Healthcare Infrastructure

The availability of significant number of diagnostic labs in distinct regions of Mexico has aided the healthcare system in Mexico. Mexico ranks second in the Americas on account of number of accredited labs. The number of accredited labs in Mexico were 18 on count till 2005 which rose to a higher count of 81 in 2015. Mexico has a social security system which provides health insurance to all the formal workers and their families. For people outside the formal workforce, the public insurance scheme Seguro Popular provided insurance coverage for millions of the low-income Mexicans until its current replacement by Instituto de Salud para El Bienestar in January 2020.The new system Instituto de Salud para El Bienestar is subjected to aim to decentralized and integrate distinct public healthcare institutions to provide free healthcare to all the Mexicans in a more efficient and integrated manner and thus were providing more routinely healthcare and diagnostic facilities to the country people thereby boosting the Mexico Diagnostic Labs Market.



Download Free Sample Report


Market Segmentation

Mexico Diagnostic Labs Market is segmented into Provider Type, test type, end users, and region. Based on product type, the market can be segmented into Hospital Based Diagnostic Labs, Diagnostic Chains and Stand-Alone Diagnostic Labs. Depending on the Test type, the market can be segmented into Pathology and Radiology. Based on end users, the market can be differentiated into Walk-ins, Referrals and Corporate Clients.

 

Market Players

Laboratorio Médico del Chopo, Estudios Clínicos Dr. T.J. Oriard SA de CV, Quest Diagnostics Incorporated, Diagno, Salud Digna, Omicron Lab (Omnigenomics), Lans Laboratorios de Referencia, S.A. de C.V., etc. are some of the leading players operating in the Mexico Diagnostic Labs Market.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2024-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

           By Provider Type

           By Test Type

           By End User

           By Region

Regional scope

North, Central Mexico, Central North, South Mexico

Key companies profiled

Laboratorio Médico del Chopo, Estudios Clínicos Dr. T.J. Oriard SA de CV, Quest Diagnostics Incorporated, Diagno, Salud Digna, Omicron Lab (Omnigenomics), Lans Laboratorios de Referencia, S.A. de C.V

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, Mexico Diagnostic Labs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

·         Mexico Diagnostic Labs Market, By Provider Type:

o      Hospital Based Diagnostic Labs

o      Diagnostic Chains

o      Stand Alone Diagnostic Labs

·         Mexico Diagnostic Labs Market, By Test Type:

o      Pathology

o      Radiology

·         Mexico Diagnostic Labs Market, By End User:

o      Walk-ins

o      Referrals

o      Corporate Clients

·         Mexico Diagnostic Labs Market, By Region

o   North

o   Central Mexico

o   Central North

o   South Mexico

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Mexico Diagnostic Labs Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Mexico Diagnostic Labs Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study­­­­

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Mexico Diagnostic Labs Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Provider Type (Hospital Based Diagnostic Labs, Diagnostic Chains, Stand Alone Diagnostic Labs)

5.2.2.     By Test Type (Pathology v/s Radiology)

5.2.3.     By End User (Walk-ins, Referrals, Corporate Clients)

5.2.4.     By Region

5.2.5.     By Company (2022)

5.3.  Market Map

5.3.1.     By Provider Type

5.3.2.     By Test Type

5.3.3.     By End User

5.3.4.     By Region

6.    Mexico Hospital Based Diagnostic Labs Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Test Type

6.2.2.     By End User

7.    Mexico Diagnostic Chains Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Test Type

7.2.2.     By End User

8.    Mexico Stand Alone Diagnostic Labs Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Test Type

8.2.2.     By End User

9.    Market Dynamics

9.1.  Drivers

9.2.  Challenges

10.  Market Trends & Developments

11.  Policy & Regulatory Landscape

12.  Mexico Economic Profile

13.  Competitive Landscape

13.1.              Business Overview

13.2.              Product Offerings

13.3.              Recent Developments

13.4.              Financials (As Reported)

13.5.              Key Personnel

13.5.1.  Laboratorio Médico del Chopo

13.5.2.  Estudios Clínicos Dr. T.J. Oriard SA de CV

13.5.3.  Quest Diagnostics Incorporated

13.5.4.  Diagno

13.5.5.  Salud Digna

13.5.6.  Omicron Lab (Omnigenomics)

13.5.7.  Lans Laboratorios de Referencia, S.A. de C.V

14. Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

The increasing prevalence of cardiovascular diseases, increasing demand for diagnostic testing, and rising obesity prevalence among the population are the some of the major drivers for the Mexico Diagnostic Labs Market.

down-arrow

Laboratorio Médico del Chopo, Estudios Clínicos Dr. T.J. Oriard SA de CV, Quest Diagnostics Incorporated, Diagno, Salud Digna, Omicron Lab (Omnigenomics), Lans Laboratorios de Referencia, S.A. de C.V, etc. are some of the leading players operating in the Mexico Diagnostic Labs Market.

down-arrow

Radiology is the segment type expected to dominate in the market for the forecast period.

down-arrow

Northern Mexico is estimated to demonstrate significant growth during the forecast period.

profile

Sakshi Bajaal

Business Consultant
Press Release

Mexico Diagnostic Labs Market to be dominated by Radiology segment through 2028

Dec, 2022

Increasing prevalence of obesity among the population is expected to drive Mexico Diagnostic Market growth in the forecast period, 2024-2028.